This story was first published in digitalhealth.net

Men across England could benefit from faster diagnosis and quicker treatment of prostate cancer following the expansion of a pioneering trial of Artificial Intelligence to analyse biopsies.
In the UK, nearly 100,000 men undergo a prostate biopsy every year - a number expected to double in the next ten years. More than 40,000 men are diagnosed with prostate cancer in England every year.
The technology is designed to help reduce diagnostic errors and speed up diagnosis. Clinicians will compare the results of the AI analysis to current diagnosis methods, where biopsies are meticulously reviewed by a pathologist.
Imperial College Healthcare, University College London, University Hospital of Coventry & Warwickshire, Chelsea and Westminster Hospital and University Hospital Southampton are joining the study.
Funded as part of the £140 million NHSX AI in Health and Care awards, the study will enable leading researchers to evaluate the effectiveness of the AI solution Galen™ Prostate in detecting and grading cancer in prostate biopsies using samples from 600 men over 14 months.
The funding will be used for deploying and evaluating the AI technology, with the potential for it to be adopted more widely across the health service, cutting diagnosis times and freeing up valuable clinician time.
Sajid Javid, Health and Social Care Secretary, said: “Artificial intelligence has the potential to transform our health and care system and studies like this are vital in understanding the impact AI can make.
“Cancer diagnosis and treatment has remained a top priority throughout the pandemic and I am committed to busting the backlog in cancer care. The earlier cancer is detected the quicker it is treated leading to better outcomes for patients, so this ground-breaking work has the potential to benefit thousands of people.”
Matthew Gould, NHSX CEO, said: “We are currently caught between having too few pathologists and rising demand for biopsies. This technology could help, and give thousands of men with prostate cancer faster, more accurate diagnoses. It is a prime example of how AI can help clinicians improve care for patients as we recover from the pandemic.”
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly